Back
Direxion Daily S&P Biotech Bull 3X Shares Vs. Aligos Therapeutics Industry Stock Comparison
Sell
6
LABU
Direxion Daily S&P Biotech Bull 3X Shares
Last Price:
$94.18
Seasonality Move:
-9.57%
Buy
62
ALGS
Aligos Therapeutics
Last Price:
$39.78
Seasonality Move:
7.18%
Sell
6
Direxion Daily S&P Biotech Bull 3X Shares (LABU)
is a Sell
Is Direxion Daily S&P Biotech Bull 3X Shares a Buy, Sell or Hold?
-
The current Direxion Daily S&P Biotech Bull 3X Shares [LABU] share price is $89.79. The Score for LABU is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
-
LABU is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
62
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $38.35. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LABU Stock Price Chart
What is Direxion Daily S&P Biotech Bull 3X Shares's stock price today?
-
The Direxion Daily S&P Biotech Bull 3X Shares share price today is $89.79Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LABU is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $38.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
LABU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.71 | Sell |
Relative Strength Index (14 RSI): | 31.07 | Sell |
Chaikin Money Flow: | 581295 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (101.31 - 122.15) | Sell |
Bollinger Bands (100): | (113.17 - 136.65) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.1 | Buy |
Relative Strength Index (14 RSI): | 79.33 | Buy |
Chaikin Money Flow: | 265554 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.3 - 32.5) | Buy |
Bollinger Bands (100): | (7.16 - 22.66) | Buy |
LABU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.86 | Sell |
20-day SMA: | 113.34 | Sell |
50-day SMA: | 120.35 | Sell |
200-day SMA: | 120.63 | Sell |
8-day EMA: | 102.06 | Sell |
20-day EMA: | 110.28 | Sell |
50-day EMA: | 117.6 | Sell |
200-day EMA: | 120.87 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34 | Buy |
20-day SMA: | 28.23 | Buy |
50-day SMA: | 17.95 | Buy |
200-day SMA: | 16.14 | Buy |
8-day EMA: | 33.62 | Buy |
20-day EMA: | 28.8 | Buy |
50-day EMA: | 21.66 | Buy |
200-day EMA: | 17.2 | Buy |
Direxion Daily S&P Biotech Bull 3X Shares Earnings Growth & LABU Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Direxion Daily S&P Biotech Bull 3X Shares Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |